CBC News and the British Medical Journal (BMJ) are reporting that Professor Peter Doshi has won a major legal victory against pharmaceutical companies trying to hide clinical trial data from the public due to “confidential agreements” for 5 pharmaceutical products.

Doshi sued Health Canada to release clinical trial data submitted to Health Canada by the manufacturers of the HPV vaccines Gardasil, Gardasil 9 and Cervarix, and the anti-viral flu medications, Tamiflu and Relenza.

A Canadian Federal Court judge ordered Health Canada to release the pharmaceutical clinical trial data, undercutting the Canadian government’s attempts to keep the information confidential.

As far as I can determine, this landmark court ruling out of Canada has been completely censored in the U.S. corporate-sponsored “mainstream” media.

This appears to be a brilliant legal strategy by Doshi and his attorneys, since they had little to no chance of obtaining this clinical trial data from any court in the U.S., where pharmaceutical companies enjoy legal immunity from most lawsuits.

The importance of receiving this data, particularly on Merck’s Gardasil vaccine, cannot be overstated.

As we have reported many times here at Health Impact News, the entire medical approval process to bring the HPV vaccine into the U.S. market is full of scandals and cover-ups, which has resulted in the injuries and deaths of many young people, particularly young women aged 12 to 26, many of whom can no longer bear children due to the vaccine making them infertile.

“I hope my case sets a precedent and allows researchers, clinicians, and the public easy access to clinical trial data,” Doshi reportedly stated in an email to CBC News.

“Regulators shouldn’t have a monopoly on judging the risks and benefits of medicines or hinder others from doing the same via confidentiality agreements.”